18 related articles for article (PubMed ID: 38552713)
1. Drusen in AMD from the Perspective of Cholesterol Metabolism and Hypoxic Response.
Ban N; Shinojima A; Negishi K; Kurihara T
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731137
[TBL] [Abstract][Full Text] [Related]
2. Joint Antiangiogenic Effect of ATN-161 and Anti-VEGF Antibody in a Rat Model of Early Wet Age-Related Macular Degeneration.
Wang WQ; Wang FH; Qin WX; Liu HY; Lu B; Chung C; Zhu J; Gu Q; Shi W; Wen C; Wu F; Zhang K; Sun XD
Mol Pharm; 2016 Sep; 13(9):2881-90. PubMed ID: 27089240
[TBL] [Abstract][Full Text] [Related]
3. Wnt5a/β-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration.
Liu D; Du J; Xie H; Tian H; Lu L; Zhang C; Xu GT; Zhang J
J Neuroinflammation; 2024 Mar; 21(1):75. PubMed ID: 38532410
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells.
Saidak Z; Le Henaff C; Azzi S; Marty C; Da Nascimento S; Sonnet P; Marie PJ
J Biol Chem; 2015 Mar; 290(11):6903-12. PubMed ID: 25631051
[TBL] [Abstract][Full Text] [Related]
5. Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.
Al-Yafeai Z; Yurdagul A; Peretik JM; Alfaidi M; Murphy PA; Orr AW
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2601-2614. PubMed ID: 30354234
[TBL] [Abstract][Full Text] [Related]
6. Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.
Renner G; Noulet F; Mercier MC; Choulier L; Etienne-Selloum N; Gies JP; Lehmann M; Lelong-Rebel I; Martin S; Dontenwill M
Oncotarget; 2016 Sep; 7(38):62194-62207. PubMed ID: 27613837
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin binds integrin α5β1 to regulate macular neovascularization through the Wnt/β-catenin signaling pathway.
Zhao X; Hu L; Liu G; Yin X; Gong Q; Li Y; Li Q; Zhou Y; Sun Y; Guo C; Du Z
Exp Eye Res; 2024 May; 242():109880. PubMed ID: 38552713
[TBL] [Abstract][Full Text] [Related]
8. Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications.
Bonadio JD; Bashiri G; Halligan P; Kegel M; Ahmed F; Wang K
Adv Drug Deliv Rev; 2024 Jun; 209():115303. PubMed ID: 38588958
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
